These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34649077)

  • 1. Deiodinase-3 is a thyrostat to regulate podocyte homeostasis.
    Agarwal S; Koh KH; Tardi NJ; Chen C; Dande RR; WerneckdeCastro JP; Sudhini YR; Luongo C; Salvatore D; Samelko B; Altintas MM; Mangos S; Bianco A; Reiser J
    EBioMedicine; 2021 Oct; 72():103617. PubMed ID: 34649077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of thyroid hormone signaling triggers the diabetes-induced pathological growth, remodeling, and dedifferentiation of podocytes.
    Benedetti V; Lavecchia AM; Locatelli M; Brizi V; Corna D; Todeschini M; Novelli R; Benigni A; Zoja C; Remuzzi G; Xinaris C
    JCI Insight; 2019 Sep; 4(18):. PubMed ID: 31534055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of rituximab on puromycin-induced apoptosis, loss of adhesion and cytoskeletal alterations in human podocytes.
    Jeruschke S; Alex D; Hoyer PF; Weber S
    Sci Rep; 2022 Jul; 12(1):12297. PubMed ID: 35853959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.
    Veron D; Villegas G; Aggarwal PK; Bertuccio C; Jimenez J; Velazquez H; Reidy K; Abrahamson DR; Moeckel G; Kashgarian M; Tufro A
    PLoS One; 2012; 7(7):e40589. PubMed ID: 22808199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage.
    Lv Q; Han X; Ni J; Ma Q; Dai R; Liu J; Liu J; Zhai Y; Shen Q; Sun L; Liu H; Rao J; Xu H
    Cell Death Dis; 2022 Oct; 13(10):867. PubMed ID: 36229446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel splicing variant of small nucleolar RNA host gene 4 is a podocyte-selective non-coding RNA upregulated in response to puromycin aminonucleoside-induced podocyte injury.
    Horikawa A; Yoneda T; Yaoita E; Yamaguchi K; Shigenobu S; Kuramochi M; Yamate J; Inui T; Ishibashi O
    J Biochem; 2019 May; 165(5):447-454. PubMed ID: 30597036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of kidney barrier function by the urokinase receptor.
    Wei C; Möller CC; Altintas MM; Li J; Schwarz K; Zacchigna S; Xie L; Henger A; Schmid H; Rastaldi MP; Cowan P; Kretzler M; Parrilla R; Bendayan M; Gupta V; Nikolic B; Kalluri R; Carmeliet P; Mundel P; Reiser J
    Nat Med; 2008 Jan; 14(1):55-63. PubMed ID: 18084301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.
    Shen X; Zhang Y; Lin C; Weng C; Wang Y; Feng S; Wang C; Shao X; Lin W; Li B; Wang H; Chen J; Jiang H
    J Pathol; 2020 Nov; 252(3):227-238. PubMed ID: 32686149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
    Shen X; Jiang H; Ying M; Xie Z; Li X; Wang H; Zhao J; Lin C; Wang Y; Feng S; Shen J; Weng C; Lin W; Wang H; Zhou Q; Bi Y; Li M; Wang L; Zhu T; Huang X; Lan HY; Zhou J; Chen J
    Sci Rep; 2016 Sep; 6():32087. PubMed ID: 27580845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells.
    Dentice M; Luongo C; Ambrosio R; Sibilio A; Casillo A; Iaccarino A; Troncone G; Fenzi G; Larsen PR; Salvatore D
    Gastroenterology; 2012 Oct; 143(4):1037-47. PubMed ID: 22771508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Thyroid Hormone Inactivator Enzyme, Type 3 Deiodinase, Is Essential for Coordination of Keratinocyte Growth and Differentiation.
    Mancino G; Sibilio A; Luongo C; Di Cicco E; Miro C; Cicatiello AG; Nappi A; Sagliocchi S; Ambrosio R; De Stefano MA; Di Girolamo D; Porcelli T; Murolo M; Saracino F; Perruolo G; Formisano P; Stornaiuolo M; Dentice M
    Thyroid; 2020 Jul; 30(7):1066-1078. PubMed ID: 32111151
    [No Abstract]   [Full Text] [Related]  

  • 12. Loss of the podocyte glucocorticoid receptor exacerbates proteinuria after injury.
    Zhou H; Tian X; Tufro A; Moeckel G; Ishibe S; Goodwin J
    Sci Rep; 2017 Aug; 7(1):9833. PubMed ID: 28852159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells.
    Freitas BC; Gereben B; Castillo M; Kalló I; Zeöld A; Egri P; Liposits Z; Zavacki AM; Maciel RM; Jo S; Singru P; Sanchez E; Lechan RM; Bianco AC
    J Clin Invest; 2010 Jun; 120(6):2206-17. PubMed ID: 20458138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
    Shibata S; Nagase M; Fujita T
    J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin.
    Reiser J; Oh J; Shirato I; Asanuma K; Hug A; Mundel TM; Honey K; Ishidoh K; Kominami E; Kreidberg JA; Tomino Y; Mundel P
    J Biol Chem; 2004 Aug; 279(33):34827-32. PubMed ID: 15197181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling.
    Yoshioka T; Kosugi T; Masuda T; Watanabe T; Ryuge A; Nagaya H; Maeda K; Sato Y; Katsuno T; Kato N; Ishimoto T; Yuzawa Y; Maruyama S; Kadomatsu K
    Am J Pathol; 2019 Jul; 189(7):1338-1350. PubMed ID: 31014956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
    Okada T; Sakaguchi T; Hatamura I; Saji F; Negi S; Otani H; Muragaki Y; Kawachi H; Shigematsu T
    Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury.
    Pengal R; Guess AJ; Agrawal S; Manley J; Ransom RF; Mourey RJ; Benndorf R; Smoyer WE
    Am J Physiol Renal Physiol; 2011 Sep; 301(3):F509-19. PubMed ID: 21613416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein modulation of proteinuric renal injury.
    Tsuchida Y; Zhong J; Otsuka T; Dikalova A; Pastan I; Anantharamaiah GM; Linton MF; Yancey PG; Ikizler TA; Fogo AB; Yang H; Kon V
    Lab Invest; 2019 Jul; 99(8):1107-1116. PubMed ID: 31019291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.